On February 28, 2017, Visualant, Incorporated (the Company) amended the terms of its Series E Warrant to purchase 1,785,714 shares of common stock to provide a downward adjustment to the exercise price in the event the Company issues common stock or instruments convertible into common stock at a price below $0.70 per share.
On February 28, 2017, The Company and the holder of its Series D preferred stock signed an Amended and Restated Registration Rights Agreement. The amendment registration rights agreement extends the time for the Company to file a registration statement with the Securities and Exchange Commission for the shares covered under the agreement to May 31, 2017.
Item 9.01 Financial Statements and Exhibits.
Form of Amendment to Series E Warrant
Form of Amended and Restated Registration Rights Agreement
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Registrant: VISUALANT, INCORPORATED
Jeff Wilson, CFO
March 6, 2017
- 2 -
makes a similar move, sign up!
Other recent filings from the company include the following:
Notice of Exempt Offering of Securities, item 06b - May 25, 2018
VISUALANT: Press Release Dated May 25, 2018 - May 25, 2018
Know Labs Appoints (Ret.) Admiral Bill Owens to its Board of Directors - May 24, 2018
Visualant, Incorporated Announces Name Change to Know Labs, Inc. and Files to Trade under New Stock Symbol - May 2, 2018